Standardization and validation issues of the ELISPOT assay
- PMID: 15937345
- DOI: 10.1385/1-59259-903-6:051
Standardization and validation issues of the ELISPOT assay
Abstract
During the last 20 yr, the enzyme-linked immunospot (ELISPOT) assay has emerged as one of the most important and widely used assays to monitor immune responses in humans and a variety of other species. With the ELISPOT assay, immune cell frequencies can be measured at the single cell level without elaborate expansion or manipulation of cell populations. Its usefulness has led to its application in vaccine design and development and, most importantly, in monitoring vaccination efforts. The impact of results measured with this assay can be profound. In addition to ease of performance, repeatability and reliability are major features expected of an ELISPOT assay. The focus today is on standardization of the technique, validation strategies to comply with these required features, and accommodation of the growing demand of Good Laboratory Practice (GLP) compliance. This chapter will give the experienced scientists as well as newcomers to the field an overview over the major standardization issues for each step of the protocol. Guidelines are given on how to validate the ELISPOT performance.
Similar articles
-
Use of interferon-gamma ELISPOT in monitoring immune responses in humans.Methods Mol Biol. 2005;302:237-52. doi: 10.1385/1-59259-903-6:237. Methods Mol Biol. 2005. PMID: 15937356
-
Measurement of cytokine release at the single cell level using the ELISPOT assay.Methods. 2006 Apr;38(4):274-82. doi: 10.1016/j.ymeth.2005.11.006. Methods. 2006. PMID: 16473524
-
Image analysis and data management of ELISPOT assay results.Methods Mol Biol. 2005;302:117-32. doi: 10.1385/1-59259-903-6:117. Methods Mol Biol. 2005. PMID: 15937348
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
-
Diagnostic value of T-cell monitoring assays in kidney transplantation.Curr Opin Organ Transplant. 2009 Aug;14(4):426-31. doi: 10.1097/MOT.0b013e32832c5999. Curr Opin Organ Transplant. 2009. PMID: 19417657 Review.
Cited by
-
Toward the harmonization of immune monitoring in clinical trials: quo vadis?Cancer Immunol Immunother. 2008 Mar;57(3):285-8. doi: 10.1007/s00262-007-0379-z. Epub 2007 Aug 25. Cancer Immunol Immunother. 2008. PMID: 17721782 Free PMC article. No abstract available.
-
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines.Cells. 2021 Nov 5;10(11):3048. doi: 10.3390/cells10113048. Cells. 2021. PMID: 34831269 Free PMC article.
-
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.Cancer Immunol Immunother. 2008 Mar;57(3):289-302. doi: 10.1007/s00262-007-0378-0. Epub 2007 Aug 25. Cancer Immunol Immunother. 2008. PMID: 17721783 Free PMC article.
-
B Cells and B Cell Blasts Withstand Cryopreservation While Retaining Their Functionality for Producing Antibody.Cells. 2018 May 31;7(6):50. doi: 10.3390/cells7060050. Cells. 2018. PMID: 29857548 Free PMC article.
-
Magnitude, breadth, and functional profile of T-cell responses during human immunodeficiency virus primary infection with B and BF viral variants.J Virol. 2008 Mar;82(6):2853-66. doi: 10.1128/JVI.02260-07. Epub 2008 Jan 9. J Virol. 2008. PMID: 18184702 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
